The biggest innovation you can make is a better decision.
Aetion Evidence Platform® delivers real-world evidence for life sciences companies, payers, and at-risk providers. We help you answer the high-stakes questions in health care: what works best, for whom, and when. Because better answers lead to better decisions.Learn more
First RCT-DUPLICATE findings published in Circulation
Initial results from the RCT-DUPLICATE project show that nine out of 10 real-world evidence studies achieved either regulatory or estimate agreement with RCTs. These results will inform the use of RWE for regulatory decision-making.Learn more
Webinar: How leading-edge R&D teams are using RWE
On Wednesday, March 10, at 10 a.m. ET/4 p.m. CET, Aetion will host a webinar with Informa on how and where RWE can enable more agile research approaches to accelerate drug development. Tune in to hear from Aetion’s Dr. Nicolle Gatto and Julie Schiffman, as well as Dr. Bob LoCasale, Head of RWE at Sanofi, and Dr. Najat Khan, Chief Data Officer at Janssen R&D.Learn more
The Evidence Hub
Want to learn more about real-world evidence? Read up on perspectives, milestones, and best practices in real-world evidence and value-based health care on our blog, the Evidence Hub.Read more
Scientific rigor for real-world evidence
As a partner to the majority of the top 20 global biopharma firms, leading payers, and the FDA, Aetion informs the most critical decisions in the industry. Our transparent analyses guide product development, commercialization, and payment innovation into health care’s modern era.
Rapid answers for decisions that matter
Aetion Evidence Platform moves the application of real-world evidence from descriptive analytics to causal conclusions. And it delivers answers within days and weeks—the rapid results needed to improve clinical and financial outcomes. Turn your best available information into insights you can use now.
Trusted evidence for all stakeholders
Our solutions begin with asking the right question and determining the right data from our commercial and academic partners around the world. Then, the analytic workflows of the platform—meeting and setting international scientific standards—enable you to validate assumptions and align stakeholders. Including on value-based care imperatives such as outcomes-based contracting.
Aetion Evidence Platform has been tremendous for us with regards to delivering RWE more efficiently. From an operational perspective, it has helped us generate high quality evidence faster, and allows us to deliver more for our stakeholders.
The most intriguing part of the Aetion story is the ability to have a very consistent analytic approach that can be applied across multiple data sets.
Aetion’s rapid turn-around time is critical, as is the fact that their analyses are based on our membership. By using predictive modeling to identify high-risk patients—who will become high-cost—we’re able to quickly engage with providers and health systems to intervene early. This improves outcomes for our highest-risk patient populations.
As part of our digital business transformation, we believe that strategic partnerships will advance our capabilities for rapid analytics. The Aetion Evidence Platform has helped reduce the completion time for UCB’s RWE initiatives by 50%, and has enhanced our capabilities to run multiple concurrent studies.
News & Events
News & Events
Los Angeles Times
Coronavirus infection leads to immunity that’s comparable to a COVID-19 vaccine
COVID-19 antibodies may protect against reinfection later, study suggests
Virtual ISPOR 2021
Should we be talking “embedded” rather than “pragmatic” for real-world clinical trials?
ISPE Mid-Year Virtual Meeting
Rise of the machines
The Evidence Digest
Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.